BURLINGTON, Mass., Feb. 19 /PRNewswire-FirstCall/ --
Palomar Medical Technologies Inc (Nasdaq: PMTI) is a leading researcher and
developer of proprietary laser/light based systems for hair removal and other
cosmetic treatments. The Company will be presenting its latest products at the
American Academy of Dermatology's 60th Annual Meeting, in New Orleans, LA,
from February 23 to 26, 2002, and will be available to give investor
demonstrations and discuss its full line of products at booth #1915.
(Photo: http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO )
At the meeting, Palomar will announce a number of new and exciting hand
pieces for additional cosmetic applications for the Palomar EsteLux(TM)
system. The Company has recently introduced a number of laser/light-based
products, including: the new Palomar EsteLux pulsed-light system for hair and
pigmented lesion removal, the new Palomar Q-YAG 5(TM) laser system for tattoo
and pigmented lesion removal and the Palomar SLP1000(TM) diode laser system
for hair removal and vascular treatments. Shipments of the Palomar EsteLux
system and the Palomar Q-YAG 5 system began at the end of the third quarter
ended September 30, 2001. Doctors can now offer their patients affordable
cosmetic laser/light-based treatments for all hair and skin types. This family
of products will help the Company increase its revenues and gross profit over
the next few quarters.
Palomar's laser/light-based cosmetic technology is among the most advanced
in the industry. Palomar invested considerable resources to ensure that its
patent portfolio and other intellectual property provide strong protection of
its technology. The strength of Palomar's patents is validated by its 7.5
percent license program, which continues to be expanded throughout the
industry.
To reserve a time to meet with Palomar management and/or receive product
demonstrations, please contact Paul Weiner, Treasurer and Investor Relations
Officer, of Palomar Medical Technologies, Inc. at 1-800-PALOMAR or
ir@palmed.com or Rob Weir, Account Manager at Palomar's investor relations'
firm Allen & Caron, Inc., at 212-691-8087 or robw@allencaron.com.
About Palomar Medical Technologies Inc:
Palomar is the leading researcher and developer of laser/light based
systems for hair removal and other cosmetic treatments and is the first
company to obtain clearance from the FDA for "permanent hair reduction.
"Palomar systems have been installed in practices worldwide, and hundreds of
thousands of treatments have been performed. New and exciting indications are
being tested to further advance the hair removal market and other cosmetic
applications including fat reduction, acne treatment and skin rejuvenation.
To get more information regarding Palomar and its products, please visit
Palomar's web site at http://www.palmed.com. Also, to continue to receive the most
up-to-date information and latest news on Palomar as it happens, sign up to
receive automatic e-mail alerts by going to the e-mail alerts page in the
Investor Relations' section of the web site.
With the exception of the historical information contained in this
release, the matters described herein contain forward-looking statements,
including but not limited to statements relating to new markets, development
and introduction of new products, and financial projections that involve risk
and uncertainties that may individually or mutually impact the matters herein,
and cause actual results, events and performance to differ materially from
such forward-looking statements. These risk factors include, but are not
limited to, results of future operations, technological difficulties in
developing or introducing new products, the results of future research, lack
of product demand and market acceptance for current and future products, the
effect of economic conditions, the impact of competitive products and pricing,
governmental regulations with respect to medical devices, including whether
FDA clearance will be obtained for future products, the results of litigation,
potential infringement of third-party intellectual property rights, and/or
other factors, which are detailed from time to time in the company's SEC
reports, including the report on Form 10-K for the year ended December 31,
2000 and the Company's quarterly reports on Form 10-Q. Readers are cautioned
not to place undue reliance on these forward-looking statements, which speak
only as of the date hereof. The company undertakes no obligation to release
publicly the result of any revisions to these forward-looking statements that
may be made to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
Contact: Paul S. Weiner,
Treasurer
781-993-2411
ir@palmed.com
SOURCE Palomar Medical Technologies Inc.
 back to top
Related links:
http://www.palmed.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20000308/PMTILOGO
PRN Photo Desk, 888-776-6555 or 212-782-2840
Company News On-Call:
http://www.prnewswire.com/comp/107555.html
CONTACT:
Paul S. Weiner, Treasurer of Palomar Medical
Technologies Inc., +1-781-993-2411
|
